Observational Study of Electrical Impedance Tomography for Non-Invasive Assessment of Cerebral Autoregulation in Neurocritical Patients

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Homeostasis Interventions: Other: Non-invasive cerebral Electrical Impedance Tomography (EIT) monitoring Sponsors: Xijing Hospital Not yet recruiting Conditions: Homeostasis Interventions: Other: Non-invasive cerebral Electrical Impedance Tomography...

Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Multiple Myeloma in Relapse; Multiple Myeloma, Refractory Interventions: Biological: Administration of CAR T-cells at 3 different dose levels Sponsors: Kure Cells, INC; CellServe LLC; Roya Clinical Not yet recruiting Conditions: Multiple Myeloma in...

Real-World Patterns of Utilization of Lenalidomide-based Triplet Regimens in FIrst RElapsed Multiple Myeloma Patients: Evidence From Medical Record Review

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Multiple Mieloma; First Relpase; Rd-base Triplet Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Completed Conditions: Multiple Mieloma; First Relpase; Rd-base Triplet Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia...

Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinence

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Fecal Incontinence Interventions: Device: Home-based anal electrical stimulator Sponsors: University Hospital, Martin; Comenius University Recruiting Conditions: Fecal Incontinence Interventions: Device: Home-based anal electrical stimulator Sponsors:...

Oral Health and Systemic Diseases: Survey of General Practitioners

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Periodontal Disease; Diabete Mellitus Interventions: Other: Questionnaire Survey Sponsors: University of Roma La Sapienza Recruiting Conditions: Periodontal Disease; Diabete Mellitus Interventions: Other: Questionnaire Survey Sponsors: University of Roma...

SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinoma

by palligoelme@gmail.com | May 27, 2026 | Clinical Trials

​ Conditions: Gastroesophageal Junction Adenocarcinoma Interventions: Drug: Tislelizumab; Drug: SKB315 for injection; Drug: Capecitabine Sponsors: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Not yet recruiting Conditions: Gastroesophageal Junction Adenocarcinoma...